Stay updated on PD-1 and NK Immunotherapy Combo in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the PD-1 and NK Immunotherapy Combo in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PD-1 and NK Immunotherapy Combo in Solid Tumors Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The new screenshot appears to show only UI and layout updates (header, spacing, font) without changes to core trial details such as enrollment, locations, eligibility, or outcome measures. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:33:45.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    38 days ago
    Change Detected
    Summary
    - Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.
    Difference
    5%
    Check dated 2025-10-05T11:51:48.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Update the page version from v3.0.2 to v3.1.0, reflecting a newer release metadata.
    Difference
    0.1%
    Check dated 2025-09-28T09:27:27.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Version bumped from v3.0.1 to v3.0.2; the Back to Top link was removed. No substantive content changes were detected.
    Difference
    0.3%
    Check dated 2025-09-13T23:56:38.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.
    Difference
    0.3%
    Check dated 2025-09-06T18:22:45.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, while key terms related to pembrolizumab and various pharmacological classifications have been removed.
    Difference
    2%
    Check dated 2025-08-30T15:24:52.000Z thumbnail image

Stay in the know with updates to PD-1 and NK Immunotherapy Combo in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PD-1 and NK Immunotherapy Combo in Solid Tumors Clinical Trial page.